Iradimed (IRMD) Revenue Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 12.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.41% |
| Dec 31, 2025 | 15.15% |
| Sep 30, 2025 | 16.51% |
| Jun 30, 2025 | 17.07% |
| Mar 31, 2025 | 16.59% |
| Dec 31, 2024 | 17.76% |
| Sep 30, 2024 | 18.88% |
| Jun 30, 2024 | 22.26% |
| Mar 31, 2024 | 24.03% |
| Dec 31, 2023 | 26.87% |
| Sep 30, 2023 | 28.94% |
| Jun 30, 2023 | 33.40% |
| Mar 31, 2023 | 21.27% |
| Dec 31, 2022 | 10.92% |
| Sep 30, 2022 | 10.40% |
| Jun 30, 2022 | 11.31% |
| Mar 31, 2022 | 13.42% |
| Dec 31, 2021 | 12.50% |
| Sep 30, 2021 | 12.73% |
| Jun 30, 2021 | 9.97% |
| Mar 31, 2021 | 9.07% |
| Dec 31, 2020 | 8.42% |
| Sep 30, 2020 | 10.61% |
| Jun 30, 2020 | 7.14% |
| Mar 31, 2020 | 18.90% |
| Dec 31, 2019 | 22.05% |
| Sep 30, 2019 | 9.10% |
| Jun 30, 2019 | -2.22% |
| Mar 31, 2019 | -2.00% |
| Dec 31, 2018 | -1.77% |
| Sep 30, 2018 | -2.41% |
| Jun 30, 2018 | -1.03% |
| Mar 31, 2018 | 0.55% |
| Dec 31, 2017 | 23.22% |
| Sep 30, 2017 | 14.28% |
| Jun 30, 2017 | 5.53% |
| Mar 31, 2017 | 13.22% |
| Dec 31, 2016 | 20.11% |
| Sep 30, 2016 | 45.72% |
| Jun 30, 2016 | 52.64% |